SCHEMBL7487134

SCHEMBL7487134

CNc1ccc2[nH]cc(C3=CCNCC3)c2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.65
ALDH1A1 P00352 4/20 0.65
HSD17B10 Q99714 4/20 0.65
HTR2C P28335 3/20 0.65
MAPT P10636 3/20 0.65
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
HTR6 P50406 2/20 0.65
HTR1D P28221 2/20 0.65
CYP1A2 P05177 2/20 0.65
CYP3A4 P08684 2/20 0.65
MAPK1 P28482 1/20 0.65
BRCA1 P38398 1/20 0.65
DRD2 P14416 1/20 0.60
ALOX15 P16050 1/20 0.60
JAK2 O60674 1/20 0.54
PRKD3 O94806 1/20 0.54
MARK3 P27448 1/20 0.54
PRKCI P41743 1/20 0.54
PRKCD Q05655 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27553752 0.84 KDM4E (0.59) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL6631651 0.82 KDM4E (0.70) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL18308980 0.82 HTR1D (0.65) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL8125400 0.81 KDM4E (0.58) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL1675799 0.80 HTR6 (0.67) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL2778860 0.80 HTR6 (0.67) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL2783986 0.80 HTR6 (0.67) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL3836149 0.80 HTR6 (0.67) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL7460028 0.80 HTR6 (0.67) KDM4EALDH1A1HSD17B10HTR2CMAPT
SCHEMBL9764393 0.79 KDM4E (0.59) KDM4EALDH1A1HSD17B10HTR2CMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086726-A1 IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 Asan BioSciences, LLC (US) 2021-05-06 WO disclosed
EP-0733628-B9 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2002-06-12 EP disclosed
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0733628-B1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2000-12-27 EP disclosed
CN-1233180-A Treatment of the common cold or allergic rhinitis LILLY CO ELI (US) 1999-10-27 CN disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5962474-A ANALGESICS; HEADACHES ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
CN-1184425-A 5-substituted-3- (1,2,3, 6-tetrahydropyridin-4-yl) -and 3- (piperidin-4-yl) -1H-indoles, 5-HT1FAgonists LILLY CO ELI (US) 1998-06-10 CN disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708008-A TREATMENT OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
WO-1996029075-A1 5-SUBSTITUTED-3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)- AND 3-(PIPERIDIN-4-YL)-1H-INDOLES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1996-09-26 WO disclosed
EP-0733628-A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed